Sarepta Therapeutics, Inc. (SRPT)
17.61
-0.03
(-0.17%)
USD |
NASDAQ |
Nov 07, 16:00
17.56
-0.05
(-0.28%)
After-Hours: 20:00
Sarepta Therapeutics Shareholders Equity (Quarterly): 1.320B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 522.31M |
| Pfizer Inc. | 92.80B |
| Elanco Animal Health, Inc. | 6.749B |
| Eli Lilly & Co. | 23.79B |
| Hims & Hers Health, Inc. | 580.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.493B |
| Total Liabilities (Quarterly) | 2.173B |
| Debt to Equity Ratio | 0.947 |
| Current Ratio | 2.954 |
| Net Debt Paydown Yield | 1.19% |